Medical research centers in Texas could potentially lose hundreds of millions of dollars in funding, putting key research ...
But alas, during one of my routine six-month scans, new tumors were found in another lobe so more surgery ensued and, this time, chemotherapy, which was overseen at the NIH Clinical Center.
On the second floor of The Laurelton, a school-turned-office building in Irondequoit, Rochester Clinical Research, or RCR, studies the effectiveness of various medical treatments.
raised concerns about what would happen to clinical trials at the NIH’s on-campus hospital, the Clinical Trial Center, if they ran out of test tubes or reagents. Memoli’s memo clarified that ...
National Institutes of Health (NIH) Acting Director Matthew Memoli sought ... research while the pause is in effect, any research or clinical trials initiated before Jan. 20 can keep going ...
The NIH, the nation’s top funder of biomedical ... halted or cancelled studies and clinical trials, and even the collapse of biomedical discovery in the United States down the line.
Advisory council meetings, which determine if an application should receive a recommendation for funding from an NIH institute or center, were also cancelled. “I don’t know that there’s a ...
WASHINGTON — The National Institutes of Health’s myriad divisions can start new work on mission-critical research, and continue working on ongoing studies, but cannot publicly communicate ...
Andrew Stanton is a Newsweek weekend reporter based in Maine. His role is reporting on U.S. politics and social issues. Andrew joined Newsweek in 2021 from The Boston Globe. He is a graduate of ...
A "huge" number of nurses from the NIH Clinical Center were also fired, the official said. Some employees who have been with the agency for decades and not on probation also received dismissal ...
Louisiana's public and private research centers got more than $190 million in NIH ... center. At Pennington, the grant money powers several research centers, including the Louisiana Clinical ...
The NIH says funding cuts would save it billions of dollars a year. D.C.-area industry and academic leaders say it would cripple R&D.